Dr. Gerald Diaz @GeraldMD
30.1M 13.9K 7.3K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
11 results
idsa infections medications opportunistic prevention drugs antibiotics mycobacterium adjunct anaerobic aviumcomplex bacteria borderline bpd candida candidiasis capsulatum cdifficile clostridium clostridiumdifficile
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020 #Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of Treatment ... Agents for COVID ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Drugs Used for the Treatment of COVID-19 Infection LOPINAVIR / RITONAVIR INTERFERON Beta-I REMDESIVIR HYDROXYCHLOROQUINE TOCILIZUMAB Piotr Okupski @PiotrOkupski - Original Infographic
Drugs Used for the Treatment ... of COVID-19 Infection ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Drugs Used for the Treatment of COVID-19 Infection ** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... of COVID-19 Infection ... HCQ treatment would ... #COVID19 #Pharmacology ... #Table #Management
IDSA 2017 CDiff Guidelines - TableΒ 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... infection Episode #Pharmacology ... #Management #CDiff
Antibiotics for Anaerobic Bacteria - Metronidazole (Flagylβ„’) - Carbapenems - Ξ² lactam +
out of favor for treatment ... out of favor for C.diff ... Anaerobic #Bacteria #Pharmacology ... #Table #Susceptibility ... #Coverage #Management
Summary of meta-analysis of pharmacotherapy trials in BPD https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder Meta-analyses of RCTs were undertaken for the following outcomes:
with β€˜treatment ... updated systematic review ... summarised in Tables ... #Pharmacology # ... Effectiveness #Table
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode Proven efficacy: β€’ Vancomycin -
Potential Treatment ... Agents for Treatment ... Γ— 10 days #CDiff ... #management #pharmacology ... #idsa #table
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS Indications for Initiating Primary Prophylaxis: β€’
with ARV (see Table ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS Treating LTBI (to prevent TB disease) Indications:
prior history of treatment ... Please refer to the table ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
empty